Digital Assets Report


Like this article?

Sign up to our free newsletter

Direxion expands alternative investment team with addition of new MD

Related Topics

Direxion, a leader in alternative investment solutions, has appointed Edward Egilinsky as Managing Director, Head of Alternative Investments. As a member of Direxion’s management team, Egilinsky will drive the firm’s product development initiatives, internal and external messaging, training and support of product delivery.  

"Ed’s past success in building out alternative investment products and platforms dovetail perfectly with Direxion’s proven capabilities in alternative strategies," says Direxion President Dan O’Neill. "He will play an integral role in helping us develop and distribute products as part of our continued commitment to expanding "buy and hold" alternative strategies for investors."

Egilinsky brings more than 19 years business development experience in the alternative investment industry, including having held several senior sales management positions and raising multiple billions of dollars in assets for a number of investment firms. Most recently, he served as Managing Director for Price Asset Management, where he helped lead product distribution, sales and new product initiatives.

Prior to that, Egilinsky served as Managing Director and Head of Alternative Strategies for Rydex Investments, providing leadership to the sales team for alternative strategy initiatives and expanding the firm’s distribution channels to include family offices, registered investment advisors, national investment firms, regional firms and independent advisors. He was instrumental in launching the first open-end mutual fund to give retail investors access to managed futures.

"Direxion has continually proven its commitment to product innovation and its dedication to offering alternative investment solutions for advisors and investors," says Egilinsky. "I am proud to be a part of the Direxion’s team and look forward to providing continued innovation to our clients."

Like this article? Sign up to our free newsletter

Most Popular

Further Reading